Spero Therapeutics, Inc. ($SPRO)
Rajavelu Esther โ Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
37,101
Price
$2.36
Total Value
$87,558.36
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Rajavelu Esther |
|---|---|
| Title | Chief Executive Officer, Chief Financial Officer and Chief Business Officer |
| Transaction Date | Feb 6, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 6, 2026 |
| Shares Sold | 37,101 |
| Price per Share | $2.36 |
| Total Value | $87,558.36 |
| Shares Owned After | 1,062,907 |
| Derivative | No |
| Accession Number | 0001193125-26-043336 |
| Document | View SEC Filing |